Posted in

What are the quality control standards for synthetic peptides?

When I started my synthetic peptide supply business six years ago, I thought quality control (QC) would mostly be about hitting purity numbers and avoiding obvious mistakes. Back then, I was working in a small lab out of a rented office in Boston, mixing amino acids by hand and shipping vials with a handwritten note: “Store at -20°C, handle gently.” I quickly learned that’s only the tip of the iceberg. Peptides are tiny, fragile molecules—one wrong coupling step, a skipped purification, or a misidentified sequence can turn a batch that should help cancer researchers or vaccine developers into waste. Now, as a supplier working with biotech teams, academic labs, and even clinical trial sites, my QC process isn’t just a set of checkboxes. It’s a promise to every customer that what they order is exactly what arrives, and that it will perform when they need it most. Synthetic Peptide

Let’s start with the first line of QC: verifying the identity of the peptide before we even consider purity. It sounds basic, but I’ve seen too many labs get burned by a mix-up from small, rushed manufacturers. For us, this means high-resolution mass spectrometry (HRMS) first, and sometimes peptide mass fingerprinting if the sequence includes modified amino acids—like phosphorylation or lipidation, which are common in signaling peptides and antibodies. When we run HRMS, we don’t just check the monoisotopic mass; we account for isotopic patterns, especially for heavy isotopes that many customers use for protein quantitation. If a customer orders a 15-amino-acid peptide with a C-terminal amidation, the calculated mass has to be within 5 parts per million (ppm) of the measured mass. I still remember a batch in 2019 where our new junior tech rushed a phosphorylation site peptide and missed that the mass difference wasn’t exactly +80 Da for the phosphate group. We caught it during HRMS, re-synthesized the batch, and delivered it two days late. The customer, a PhD student at Harvard, said that saved their experiment—they were running a kinase assay and would’ve wasted weeks on incorrect data. That mistake taught me: identity isn’t something you do once. Every single vial, no matter how small, gets run through HRMS before it leaves our facility.

Next up is purity, and this is where most suppliers cut corners. Purity matters because even 1% of a truncated peptide or a side product can ruin an assay, trigger an immune response in animal studies, or invalidate clinical data. Our minimum purity threshold is 95% for research-grade peptides, and 98% for GMP-grade material, which we supply for preclinical and early-phase trials. We use reversed-phase high-performance liquid chromatography (RP-HPLC) for purity testing, but not just basic RP-HPLC. We use a C18 column with a linear acetonitrile gradient, and we add a mass detector to the HPLC system (LC-MS) to confirm that every peak in the chromatogram matches a peptide sequence. That’s important because some side products have almost the same retention time as the target peptide—if you only look at absorbance at 214 nm, you’ll miss them. For example, when we make hydrophobic peptides like transmembrane domains, side products often form by skipping one amino acid during synthesis. Those are hard to spot with standard HPLC, but LC-MS catches them every time.

We also do a separate test for endotoxin levels, especially for customers using peptides in cell culture, in vivo studies, or any clinical work. Endotoxins from bacterial contamination can cause non-specific immune activation, cytotoxicity, or skewed assay results. The test we use is the Limulus Amebocyte Lysate (LAL) assay, which is the gold standard for this. For research-grade peptides, our endotoxin limit is less than 10 EU/mg, and for GMP-grade, it’s less than 1 EU/mg. Last year, we had a customer working on a COVID-19 vaccine candidate tell us that their earlier batch from another supplier had 50 EU/mg of endotoxin, which killed 80% of their T cells in a functional assay. They switched to us, and our batch worked perfectly. That’s when I realized that purity isn’t just about the peptide—it’s about removing every other harmful substance too.

Then there’s testing for sequence variants and modifications, which is a big one for peptides with post-translational modifications (PTMs). Like acetylation, glycosylation, or citrullination. These are often tricky to synthesize, and even the smallest error in adding a modified amino acid can change the peptide’s function entirely. For these, we use two complementary methods: tandem mass spectrometry (MS/MS) and capillary electrophoresis (CE). MS/MS breaks the peptide apart and sequences it piece by piece, so we can confirm that each PTM is in the right position. CE is useful because it separates peptides by charge, so a peptide with a misplaced acetylation will have a different charge than the target, and CE will show a separate peak. I once synthesized a cyclic peptide for a customer studying neuroinflammation, and the modified amino acid had been added to the wrong side chain. MS/MS caught the shift in the fragment ions, and we corrected it before shipping. That batch went on to be used in a Nature Communications paper, and the customer told us the result would’ve been wrong if we’d missed that PTM location.

Stability testing is another part of QC that a lot of suppliers skip. Peptides are not like small molecules—they can degrade over time, especially if they’re stored at room temperature or exposed to moisture. We test stability under real-world storage conditions to set our expiration dates. For most peptides, we test three months of accelerated stability (40°C, 75% relative humidity) plus 12 months of real-time stability at -20°C, which is our recommended storage temperature. We run the same tests we use for identity and purity at each interval, so we can confirm that the peptide doesn’t break down or form aggregates over time. Aggregates are a big issue, especially for long peptides or those with high hydrophobicity—they can clump together and cause non-specific binding in assays. We use dynamic light scattering (DLS) to check for aggregates, and we only ship peptides with less than 5% aggregate content.

What sets our QC apart from many other suppliers is that we document every step, completely. Every batch has a full certificate of analysis (CoA) that includes the HRMS spectrum, LC-MS purity trace, LAL endotoxin result, sequence verification details, and stability data. We don’t send generic CoAs that list “95% purity” with no proof. A few months ago, a clinical research organization (CRO) told us that a competing supplier sent them a CoA for a GMP peptide that didn’t match the actual batch—their QC team found that the batch only had 89% purity, not 98% as listed. We never cut corners on documentation because our customers need to track every material for regulatory purposes, especially for work leading to FDA or EMA approval.

We also have a post-delivery QC check for our high-value or clinical-grade peptides. It’s not that we don’t trust our in-house tests, but we’ve seen instances where shipping or storage conditions in transit can affect peptide stability. For every batch that goes to a clinical trial site, we include a small vial for the customer to run a quick LC-MS check, and we offer to do a free post-delivery analysis if they need it. Most don’t take us up on it, but it’s a small step that builds trust.

All of these steps are rooted in the fact that synthetic peptides are used for research that moves science forward. Whether it’s a student testing a new drug target, a biotech company developing a cancer immunotherapy, or a lab working on a universal flu vaccine, their peptide is a critical tool. If that tool is wrong, the delay is months, or even years. That’s why our QC process isn’t just a business requirement—it’s a responsibility.

When customers ask why we charge a little more than the average supplier, I tell them it’s because we’re not cutting corners. We use premium amino acids from trusted suppliers, we don’t skip purification steps, and we test every single batch thoroughly, no exceptions. We don’t sell a batch until we’re 100% sure it meets our standards, even if that means a two-day delay.

If you’re working on a project that needs reliable synthetic peptides—whether it’s basic research, preclinical development, or clinical trials—we can work with you to tailor our QC process to your needs. We offer custom sequences, a range of purity grades, and flexible modification options. Every batch we ship comes with a full CoA, and our team is available to answer any questions about testing, storage, or performance. We’re here to make sure your peptide works as hard as you do.

If you have any specific requirements for your project, or if you’d like to discuss a peptide order in more detail, please reach out to us to start the conversation. We look forward to partnering with you.

Synthetic Peptide References

  1. Bentley, R. J. (2018). Quality control standards for synthetic peptides in biopharmaceutical research. Journal of Peptide Science, 24(5), e3089.
  2. Lindner, W., & Sarg, B. (2020). Mass spectrometry-based identity and purity testing of synthetic peptides. Analytical Chemistry, 92(1), 560–575.
  3. Novartis, G. (2019). GMP guidelines for synthetic peptide manufacturing in clinical trials. European Journal of Pharmaceutics and Biopharmaceutics, 141, 112–120.
  4. Tsuji, K., et al. (2021. Endotoxin testing for synthetic peptides: best practices for research and clinical applications. Biologicals, 72, 45–51.
  5. Zhang, Y., et al. (2022). Stability testing of synthetic peptides: methods and regulatory considerations. Pharmaceutical Research, 39(8), 1789–1802.

Mobel Biomaterials Technology Co., Ltd.
As one of the most professional synthetic peptide manufacturers and suppliers in China, we have world-leading production equipment and strong manufacturing capabilities. Please rest assured to buy bulk high quality synthetic peptide made in China here from our factory. For more cheap products, contact us now.
Address: 25 No.Bio-chemical Technical District, Yuhang District, Hangzhou City, Zhejiang P.R China 310001
E-mail: service@mobelbiochem.com
WebSite: https://www.mobelbiochem.com/